Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling. (7th June 2021)
- Record Type:
- Journal Article
- Title:
- Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling. (7th June 2021)
- Main Title:
- Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling
- Authors:
- Qian, Ke
Yuan, Lianwen
Wang, Shalong
Kuang, Yong
Jin, Qianqian
Long, Dongju
Jiang, Yuhong
Zhao, Hua
Liu, Kuijie
Yao, Hongliang - Abstract:
- Summary: Drugs and therapies available for the treatment of inflammatory bowel disease (IBD) are not satisfactory. Our previous study has established the inhibitor of apoptosis-stimulating p53 protein (iASPP) as an oncogenic regulator in colorectal cancer by forming a regulatory axis or feedback loop with miR-124, p53, or p63. As iASPP could target and inhibit nuclear factor kappa B (NF-κB) activation, in this study the role and mechanism of iASPP in IBD was investigated. The aberrant up-regulation of iASPP in IBD was subsequently confirmed, based on online data sets, clinical sample examinations and 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)- and dextran sulfate sodium (DSS)-induced colitis mice models. TNBS or DSS stimulation successfully induced colon shortness, body weight loss, mice colon oxidative stress and inflammation. In both types of colitis mice models, iASPP over-expression improved, whereas iASPP knockdown aggravated TNBS or DSS stimulation-caused colon shortness, body weight loss and mice colon oxidative stress and inflammation. Meanwhile, in both types of colitis mice models, iASPP over-expression inhibited p65 phosphorylation and decreased the levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, C-X-C motif chemokine ligand (CXCL)1 and CXCL2 in mice colons, whereas iASPP knockdown exerted opposite effects. Graphical Abstract:
- Is Part Of:
- Clinical and experimental immunology. Volume 205:Number 2(2021)
- Journal:
- Clinical and experimental immunology
- Issue:
- Volume 205:Number 2(2021)
- Issue Display:
- Volume 205, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 205
- Issue:
- 2
- Issue Sort Value:
- 2021-0205-0002-0000
- Page Start:
- 246
- Page End:
- 256
- Publication Date:
- 2021-06-07
- Subjects:
- 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis -- dextran sulfate sodium (DSS)-induced colitis -- inflammatory bowel disease (IBD) -- inhibitor of apoptosis stimulating p53 protein (iASPP) -- NF-κB
Immunopathology -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2249 ↗
https://academic.oup.com/cei ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cei.13613 ↗
- Languages:
- English
- ISSNs:
- 0009-9104
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.251000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20720.xml